Saturday, July 11, 2026

Drug profile · INN

middle-dose

middle-dose is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — middle-dose
Class
Route
Patents
0
Programs
2
Data quality
0.70

Quick answer

middle-dose is an FDA-listed pharmaceutical active ingredient.

Key facts

INN middle-dose

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. middle-dose Norovirus Bivalent (GI.1 / GII.4) Vaccine Phase 2 · Chinese Academy of · Norovirus Infections
  2. JSVCT098 Phase 1 · Jiangsu Province Centers · COVID-19

Frequently asked questions

What is middle-dose?

middle-dose is an FDA-listed pharmaceutical active ingredient.